Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Morgan Stanley noted that two compounding groups – the Outsourcing Facilities Association and North American Custom Laboratories – filed a ...

BofA notes that Judge Mark Pittman last night ruled in favor of the Food and Drug Administration, denying the Outsourcing Facilities ...